Stents

Danis Procedure Pack SX-ELLA Stent Danis

Procedure Pack with SX-ELLA Stent Danis. Self-expandable nitinol stent preloaded in a ready-to-use delivery system. Complete procedure pack including all items required for implantation.

Features

• Variable pitches in stent weaving conform to esophageal peristalsis
– Reduced migration rates
• Standardized compression of the varices results in effective hemostasis
• Atraumatic stent ends
• Radiopaque markers at both stent ends and at the midpoint
– Acurate stent positioning
• Retrieval loops made of medical grade alloy at both stent ends
– High mechanical durability and acid resistance
• Easy endoscopic stent removal after 7 days
• Readily implantable without endoscopy
– X-Ray control, also in emergency situations
• Patient can continue an oral diet after stent implantation

Indications
– Acute bleeding from esophageal varices

Contraindications
– Esophageal strictures
– Recent radiotherapy of the esophagus
– Tumors affecting upper respiratory tract, esophagus or stomach
– Upper GIT bleeding from other causes (e.g. perforation)

Additional description

Danis Procedure Pack (019-08S-25-135) consists of a plastic carry case containing all items required for stent implantation:
Delivery system preloaded with stent, guide wire, plastic syringes, mouthpiece, kidney dish, slobber cloth, waste bag with clip, sterile gloves
Danis Procedure Pack Basic (019-08S-25-135-B) consists of: Delivery system preloaded with stent, guide wire, plastic syringe 50 ml
The delivery system 9.4 mm (28 F) / 6.6 mm (20 F) is available in a standard length of 60 cm

Article numbers

019-08S-25-135
019-08S-25-135 – B

Click here to find the product sheet

Esophageal Stent Danis Seal

Danis Seal is designed to give maximum support to assist in healing leaks.
Special innovative features make this stent the choice for this special indication.

Features

• Variable pitches in stent weaving conform to esophageal peristalsis
– Reduced migration
• Atraumatic stent ends
– Safety to use
• Radiopaque markers at both stent ends and at the midpoint
– Acurate stent positioning
• Retrieval loops made of medical grade alloy at both stent ends
– Simple endoscopic stent removal with ELLA Extractor
• Durable silicone covering
– High mechanical durability and acid resistance

Indications – Treatment of esophageal or gastric leakage from:
– Anastomotic wound dehiscence (esophagectomy, gastric bypass)
– Esophageal ruptures / perforations (spontaneous rupture – Boerhaave’s syndrome; iatrogenic rupture / perforation occurring during esophageal dilations, endoscopic manipulations, traumatic esophageal ruptures due to blunt thoracic trauma)
– Patients presenting with delayed esophageal or gastric leakage (to avoid esophageal diversion). The stenting is associated with decortication and muscle flap reinforcement

Contraindications
– Patients unable to pass endoscopy
– Esophageal, lung, tracheal and laryngeal malignancies or lymphoma producing non-healing leaks
– Non-viable / necrotic jejunal conduit forming gastric bypass
– Completely separated anastomosis

Additional description

Wide diameter of the stent aids optimal grip on esophageal wall.
Durable silicone covering with internal-smooth / external-roughened surface.
Smart wire pattern and flared ends reduce potential migration.
Narrow uncovered rims of the stent enable mucosal ingrowth for sealing stent-tissue interspace.
Durable metallic retrieval loops facilitate stent removal.

Article number

019-11-25-135

Click here to find the product sheet

SX-ELLA Stent Esophageal Degradable BD

BD Stent is designed for treatment of benign esophageal strictures (peptic, anastomotic, caustic) and achalasia resistant to standard therapy.

Features

• PULL delivery system
– Splittable olive tip
– Automatic detachment while stent starts releasing
– Prevention of olive entrapment
– Easy insertion and safe removal of delivery system
• Radiopaque markers
– Acurate stent positioning
• Anti-migration design
– Dual flared design
– Reduced migration rates
• Integrity and radial force of stent is maintained for 6 – 8 weeks following implantation
-Extended period of dilation compared to conventional methods
• Disintegration of stent occurs after 11 – 12 weeks following implantation
– No need for removal
• Simple compression procedure
– Compression tool available

Additional description

Stent is supposed to be compressed by compression tool into delivery system just prior to implantation.

5.9 mm / 9.4 mm (18 F / 28 F) delivery system, available in standard length of 75 cm

Recommended guide wire: 0.035” (0.89 mm) ultra stiff. Minimum length 220 cm

Article numbers

019-10A-23/18/23-060
019-10A-23/18/23-080
019-10A-23/18/23-100
019-10A-25/20/25-060
019-10A-25/20/25-080
019-10A-25/20/25-100
019-10A-28/23/28-060
019-10A-28/23/28-080
019-10A-28/23/28-100
019-10A-31/25/31-060
019-10A-31/25/31-080
019-10A-31/25/31-100
019-10A-31/25/31-135

Click here to find the product sheet

SX-ELLA Stent Esophageal HV – HV Stent Plus

HV Stent Plus is designed for palliation of malignant esophageal strictures, occlusion of esophagorespiratory fistulas and benign strictures resistant to standard therapy.
Stent system for fluoroscopic and / or endoscopic insertion.
Self-expandable fully covered nitinol stent preloaded in PULL delivery system.

Features

• Splittable olive tip*
– Automatic detachment while stent starts releasing
– Prevention of olive entrapment
– Safe removal of delivery system
• Retrieval loop made of medical grade alloy at proximal stent end
– High mechanical durability and acid-resistance
– Centripetal constriction of stentfl are
– Suitable for extraction by means of ELLA Extractor
• Radiopaque markers
– Accurate stent positioning
• Anti-migration collar**
– Reduced migration rates
• Atraumatic stent ends
– Reduction of esophageal wall irritation and hyperplasia
• Excellent flexibility
– Smooth alignment and adequate stent expansion along anatomical curves
• Durable silicone stent covering
– Prevention of tumor in-growth, occlusion of esophago respiratory fistulas

* Designed by: Hans-Ulrich Laasch, MD, MRCP, FRCR; Christie Hospital, Manchester, UK
** Designed by: UMC Utrecht, the Netherlands

Additional description

5.9 mm / 9.4 mm (18 F / 28 F) delivery system, available in standard length of 75 cm

Recommended guide wire: 0.035” (0.89 mm) ultra stiff – Minimum length 220 cm

Article numbers

019-09S-20-085
019-09S-20-110
019-09S-20-135
019-09S-20-150
019-09S-20-085-O
019-09S-20-110-O
019-09S-20-135-O
019-09S-20-150-O

Click here to find the product sheet

Extractor for SX-ELLA Esophageal Stents

ELLA Extractor is designed for extraction of SX-ELLA esophageal stents:
– SX-ELLA Stent Esophageal – Flexella
– SX-ELLA Stent Esophageal – Flexella Plus
– SX-ELLA Stent Esophageal HV – HV Stent
– SX-ELLA Stent Esophageal HV – HV Stent Plus
– SX-ELLA Stent Danis – Danis Stent

• Atraumatic stent capture
– Stent is completely retrieved into overtube prior to removal
– No shearing forces on esophageal wall
• Excellent radiopacity
– Stainless steel cable and radiopaque markers
– Precise fluoroscopic control
• Unique design
– Safe removal of stents from their original position or stents migrated into stomach
• Through-the-scope application
– Extraction cable is designed for use through working channel of standard endoscope (2.8 mm)
– Retrieval loop of stent is captured with arresting hook under direct vision

Removal recommendations
– Danis Stent, partially covered and uncovered stents should be removed within maximum of 7 (seven) days following implantation.
– after 7 days using extractor is not recommended.
– Removal of fully covered stents placed in benign strictures should be performed within 4 weeks after stent implantation.
– In addition ELLA Extractor may be used for retrieval of both covered and uncovered stents that migrated into stomach.

Additional description

9.4 mm (28 F) / 100 cm overtube with distal radiopaque marker

2.6 mm / 150 cm stainless steel extraction cable consisting of central wire with arresting hook and braided sheath

Article number

015-01-28-1000

Click here to find the product sheet

Endoscopic Marker

BLACK EYE™ Endoscopic Marker

The first and only non-India-ink-based product for marking the GI tract.

BLACK EYE™ is a sterile, non-pyrogenic solution designed to be used as an endoscopic marker for marking polyps and lesions in the gastrointestinal tract. It is supplied in syringes which contain 5ml of the marker solution.

The solution is sterilized and aseptically packed in the syringe. It is supplied sterile and disposable. BLACK EYE™ is indicated for endoscopically marking of lesion in the GI track.

BLACK EYE™ is both CE-marked and FDA cleared.

Article number
TS-205

Click here to find product sheet

Mucosal Resection

EndoRotor®

The EndoRotor® is a next generation interventional resection device designed to address challenges of sessile lesions and incomplete resection.

The EndoRotor® is indicated for endoscopic resection of tissue from within the GI tract.

The tool resects and removes mucosal tissue simultaneously through a catheter inserted into the working channel of an endoscope.

This interventional tool replaces multiple instruments and the time necessary for instrument exchange.

Features
• Single resection tool designed for mucosal lesions
• Designed to address sessile/ flat lesions by suctioning and cutting in 1 motion
• Designed to address the challenges of tissue bridges
• Designed to address tissue around the lateral margin
• Has the potential to replace the need for multiple instruments with 1 and eliminate the time necessary for the exchange of multiple instruments

Article number
ER 10-01: 
Endorotor® Catheter
ER EGD 10-01: Endorotor® EGD Catheter
ERC 20-01: Endorotor® Console, with foot pedal and power cord
ER 30-01: Endorotor® Specimen Trap
ER 40-01: Endorotor® Filter

Click here to find the product sheet

Injection Needles